INTERNATIONAL JOURNAL OF ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=549996, encodeId=3733549996fb, content=太耽误时间了.怎么这么无耻!scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, beContent=scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Dec 14 00:00:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549924, encodeId=714454992404, content=审稿速度:3.0 经验分享：9月份投稿，期间修图2次，中间transfer offered，之后邮件通知withdrawn,也是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8rWmC7IqnkYnlgBw4xSYXQNScbVfhIibs409oNsTMoZyLaxAPla2AWNS1IGSoxUC9FOYrH0MlDFQ/132, createdBy=379a2105901, createdName=scalpel_wielder, createdTime=Tue Dec 12 13:37:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549889, encodeId=07da549889bc, content=这个杂志submitted要多久?效率真够低的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Dec 11 10:17:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549838, encodeId=f9fd5498388f, content=submitted一周了.什么情况啊.效率真不敢恭维!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Dec 08 12:03:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549706, encodeId=aa8c549e068a, content=我也出现了这个问题，请问怎么拒绝转投？状态显示是transfer offeredIvyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, beContent=Ivyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170210/IMG589DE318D473F7832.jpg, createdBy=305b1731653, createdName=wxsession2fd6bdf4, createdTime=Mon Dec 04 17:12:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548223, encodeId=cdc35482237e, content=20多天转投oncology report,老板不同意.撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe5b2075564, createdName=1311f10cd2m, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548240, encodeId=2932548240c6, content=oncology report也有2.66...你老板咋想的?131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, beContent=131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4ac1648838, createdName=Ou Chunlin, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548116, encodeId=c5fb548116fa, content=7月底投稿，2周后受到邮件让改格式，改完迅速发过去，7+周过去了，刚刚受到邮件通知要under review了......那么这7+周他们在干什么呢....请问从under review到知道结果大概还要多久呀？一般几个reviewer呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12682133049, createdName=zhijiena_94096875, createdTime=Wed Oct 11 03:14:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547981, encodeId=da4b54e98109, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7月16日审稿，10月4日接受。期间小修一次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea411918519, createdName=BRIGHTINS, createdTime=Sat Oct 07 14:14:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547784, encodeId=094b54e784e5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月5号投稿.今天接收了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/05/39a731df1ff0b576e2c6bee247ac045d.jpg, createdBy=1a571649504, createdName=715498212, createdTime=Sat Sep 30 06:01:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]

2017-12-14 sunliang

太耽误时间了.怎么这么无耻!scalpel_wielder 2017-12-12 13:37:00 发表:
9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了

scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了

186 0

[GetPortalCommentsPageByObjectIdResponse(id=549996, encodeId=3733549996fb, content=太耽误时间了.怎么这么无耻!scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, beContent=scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Dec 14 00:00:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549924, encodeId=714454992404, content=审稿速度:3.0 经验分享：9月份投稿，期间修图2次，中间transfer offered，之后邮件通知withdrawn,也是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8rWmC7IqnkYnlgBw4xSYXQNScbVfhIibs409oNsTMoZyLaxAPla2AWNS1IGSoxUC9FOYrH0MlDFQ/132, createdBy=379a2105901, createdName=scalpel_wielder, createdTime=Tue Dec 12 13:37:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549889, encodeId=07da549889bc, content=这个杂志submitted要多久?效率真够低的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Dec 11 10:17:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549838, encodeId=f9fd5498388f, content=submitted一周了.什么情况啊.效率真不敢恭维!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Dec 08 12:03:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549706, encodeId=aa8c549e068a, content=我也出现了这个问题，请问怎么拒绝转投？状态显示是transfer offeredIvyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, beContent=Ivyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170210/IMG589DE318D473F7832.jpg, createdBy=305b1731653, createdName=wxsession2fd6bdf4, createdTime=Mon Dec 04 17:12:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548223, encodeId=cdc35482237e, content=20多天转投oncology report,老板不同意.撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe5b2075564, createdName=1311f10cd2m, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548240, encodeId=2932548240c6, content=oncology report也有2.66...你老板咋想的?131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, beContent=131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4ac1648838, createdName=Ou Chunlin, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548116, encodeId=c5fb548116fa, content=7月底投稿，2周后受到邮件让改格式，改完迅速发过去，7+周过去了，刚刚受到邮件通知要under review了......那么这7+周他们在干什么呢....请问从under review到知道结果大概还要多久呀？一般几个reviewer呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12682133049, createdName=zhijiena_94096875, createdTime=Wed Oct 11 03:14:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547981, encodeId=da4b54e98109, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7月16日审稿，10月4日接受。期间小修一次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea411918519, createdName=BRIGHTINS, createdTime=Sat Oct 07 14:14:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547784, encodeId=094b54e784e5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月5号投稿.今天接收了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/05/39a731df1ff0b576e2c6bee247ac045d.jpg, createdBy=1a571649504, createdName=715498212, createdTime=Sat Sep 30 06:01:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]

2017-12-12 scalpel_wielder

审稿速度:3.0
经验分享：9月份投稿，期间修图2次，中间transfer offered，之后邮件通知withdrawn,也是醉了

173 0

[GetPortalCommentsPageByObjectIdResponse(id=549996, encodeId=3733549996fb, content=太耽误时间了.怎么这么无耻!scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, beContent=scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Dec 14 00:00:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549924, encodeId=714454992404, content=审稿速度:3.0 经验分享：9月份投稿，期间修图2次，中间transfer offered，之后邮件通知withdrawn,也是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8rWmC7IqnkYnlgBw4xSYXQNScbVfhIibs409oNsTMoZyLaxAPla2AWNS1IGSoxUC9FOYrH0MlDFQ/132, createdBy=379a2105901, createdName=scalpel_wielder, createdTime=Tue Dec 12 13:37:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549889, encodeId=07da549889bc, content=这个杂志submitted要多久?效率真够低的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Dec 11 10:17:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549838, encodeId=f9fd5498388f, content=submitted一周了.什么情况啊.效率真不敢恭维!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Dec 08 12:03:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549706, encodeId=aa8c549e068a, content=我也出现了这个问题，请问怎么拒绝转投？状态显示是transfer offeredIvyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, beContent=Ivyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170210/IMG589DE318D473F7832.jpg, createdBy=305b1731653, createdName=wxsession2fd6bdf4, createdTime=Mon Dec 04 17:12:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548223, encodeId=cdc35482237e, content=20多天转投oncology report,老板不同意.撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe5b2075564, createdName=1311f10cd2m, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548240, encodeId=2932548240c6, content=oncology report也有2.66...你老板咋想的?131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, beContent=131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4ac1648838, createdName=Ou Chunlin, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548116, encodeId=c5fb548116fa, content=7月底投稿，2周后受到邮件让改格式，改完迅速发过去，7+周过去了，刚刚受到邮件通知要under review了......那么这7+周他们在干什么呢....请问从under review到知道结果大概还要多久呀？一般几个reviewer呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12682133049, createdName=zhijiena_94096875, createdTime=Wed Oct 11 03:14:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547981, encodeId=da4b54e98109, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7月16日审稿，10月4日接受。期间小修一次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea411918519, createdName=BRIGHTINS, createdTime=Sat Oct 07 14:14:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547784, encodeId=094b54e784e5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月5号投稿.今天接收了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/05/39a731df1ff0b576e2c6bee247ac045d.jpg, createdBy=1a571649504, createdName=715498212, createdTime=Sat Sep 30 06:01:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]

2017-12-11 sunliang

这个杂志submitted要多久?效率真够低的啊

188 0

[GetPortalCommentsPageByObjectIdResponse(id=549996, encodeId=3733549996fb, content=太耽误时间了.怎么这么无耻!scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, beContent=scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Dec 14 00:00:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549924, encodeId=714454992404, content=审稿速度:3.0 经验分享：9月份投稿，期间修图2次，中间transfer offered，之后邮件通知withdrawn,也是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8rWmC7IqnkYnlgBw4xSYXQNScbVfhIibs409oNsTMoZyLaxAPla2AWNS1IGSoxUC9FOYrH0MlDFQ/132, createdBy=379a2105901, createdName=scalpel_wielder, createdTime=Tue Dec 12 13:37:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549889, encodeId=07da549889bc, content=这个杂志submitted要多久?效率真够低的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Dec 11 10:17:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549838, encodeId=f9fd5498388f, content=submitted一周了.什么情况啊.效率真不敢恭维!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Dec 08 12:03:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549706, encodeId=aa8c549e068a, content=我也出现了这个问题，请问怎么拒绝转投？状态显示是transfer offeredIvyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, beContent=Ivyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170210/IMG589DE318D473F7832.jpg, createdBy=305b1731653, createdName=wxsession2fd6bdf4, createdTime=Mon Dec 04 17:12:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548223, encodeId=cdc35482237e, content=20多天转投oncology report,老板不同意.撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe5b2075564, createdName=1311f10cd2m, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548240, encodeId=2932548240c6, content=oncology report也有2.66...你老板咋想的?131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, beContent=131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4ac1648838, createdName=Ou Chunlin, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548116, encodeId=c5fb548116fa, content=7月底投稿，2周后受到邮件让改格式，改完迅速发过去，7+周过去了，刚刚受到邮件通知要under review了......那么这7+周他们在干什么呢....请问从under review到知道结果大概还要多久呀？一般几个reviewer呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12682133049, createdName=zhijiena_94096875, createdTime=Wed Oct 11 03:14:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547981, encodeId=da4b54e98109, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7月16日审稿，10月4日接受。期间小修一次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea411918519, createdName=BRIGHTINS, createdTime=Sat Oct 07 14:14:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547784, encodeId=094b54e784e5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月5号投稿.今天接收了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/05/39a731df1ff0b576e2c6bee247ac045d.jpg, createdBy=1a571649504, createdName=715498212, createdTime=Sat Sep 30 06:01:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]

2017-12-08 sunliang

submitted一周了.什么情况啊.效率真不敢恭维!

211 0

[GetPortalCommentsPageByObjectIdResponse(id=549996, encodeId=3733549996fb, content=太耽误时间了.怎么这么无耻!scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, beContent=scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Dec 14 00:00:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549924, encodeId=714454992404, content=审稿速度:3.0 经验分享：9月份投稿，期间修图2次，中间transfer offered，之后邮件通知withdrawn,也是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8rWmC7IqnkYnlgBw4xSYXQNScbVfhIibs409oNsTMoZyLaxAPla2AWNS1IGSoxUC9FOYrH0MlDFQ/132, createdBy=379a2105901, createdName=scalpel_wielder, createdTime=Tue Dec 12 13:37:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549889, encodeId=07da549889bc, content=这个杂志submitted要多久?效率真够低的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Dec 11 10:17:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549838, encodeId=f9fd5498388f, content=submitted一周了.什么情况啊.效率真不敢恭维!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Dec 08 12:03:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549706, encodeId=aa8c549e068a, content=我也出现了这个问题，请问怎么拒绝转投？状态显示是transfer offeredIvyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, beContent=Ivyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170210/IMG589DE318D473F7832.jpg, createdBy=305b1731653, createdName=wxsession2fd6bdf4, createdTime=Mon Dec 04 17:12:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548223, encodeId=cdc35482237e, content=20多天转投oncology report,老板不同意.撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe5b2075564, createdName=1311f10cd2m, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548240, encodeId=2932548240c6, content=oncology report也有2.66...你老板咋想的?131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, beContent=131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4ac1648838, createdName=Ou Chunlin, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548116, encodeId=c5fb548116fa, content=7月底投稿，2周后受到邮件让改格式，改完迅速发过去，7+周过去了，刚刚受到邮件通知要under review了......那么这7+周他们在干什么呢....请问从under review到知道结果大概还要多久呀？一般几个reviewer呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12682133049, createdName=zhijiena_94096875, createdTime=Wed Oct 11 03:14:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547981, encodeId=da4b54e98109, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7月16日审稿，10月4日接受。期间小修一次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea411918519, createdName=BRIGHTINS, createdTime=Sat Oct 07 14:14:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547784, encodeId=094b54e784e5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月5号投稿.今天接收了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/05/39a731df1ff0b576e2c6bee247ac045d.jpg, createdBy=1a571649504, createdName=715498212, createdTime=Sat Sep 30 06:01:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]

2017-12-04 wxsession2fd6bdf4

我也出现了这个问题，请问怎么拒绝转投？状态显示是transfer offeredIvyphx 2016-10-22 发表::
研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci

Ivyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci

167 0

[GetPortalCommentsPageByObjectIdResponse(id=549996, encodeId=3733549996fb, content=太耽误时间了.怎么这么无耻!scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, beContent=scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Dec 14 00:00:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549924, encodeId=714454992404, content=审稿速度:3.0 经验分享：9月份投稿，期间修图2次，中间transfer offered，之后邮件通知withdrawn,也是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8rWmC7IqnkYnlgBw4xSYXQNScbVfhIibs409oNsTMoZyLaxAPla2AWNS1IGSoxUC9FOYrH0MlDFQ/132, createdBy=379a2105901, createdName=scalpel_wielder, createdTime=Tue Dec 12 13:37:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549889, encodeId=07da549889bc, content=这个杂志submitted要多久?效率真够低的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Dec 11 10:17:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549838, encodeId=f9fd5498388f, content=submitted一周了.什么情况啊.效率真不敢恭维!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Dec 08 12:03:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549706, encodeId=aa8c549e068a, content=我也出现了这个问题，请问怎么拒绝转投？状态显示是transfer offeredIvyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, beContent=Ivyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170210/IMG589DE318D473F7832.jpg, createdBy=305b1731653, createdName=wxsession2fd6bdf4, createdTime=Mon Dec 04 17:12:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548223, encodeId=cdc35482237e, content=20多天转投oncology report,老板不同意.撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe5b2075564, createdName=1311f10cd2m, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548240, encodeId=2932548240c6, content=oncology report也有2.66...你老板咋想的?131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, beContent=131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4ac1648838, createdName=Ou Chunlin, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548116, encodeId=c5fb548116fa, content=7月底投稿，2周后受到邮件让改格式，改完迅速发过去，7+周过去了，刚刚受到邮件通知要under review了......那么这7+周他们在干什么呢....请问从under review到知道结果大概还要多久呀？一般几个reviewer呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12682133049, createdName=zhijiena_94096875, createdTime=Wed Oct 11 03:14:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547981, encodeId=da4b54e98109, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7月16日审稿，10月4日接受。期间小修一次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea411918519, createdName=BRIGHTINS, createdTime=Sat Oct 07 14:14:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547784, encodeId=094b54e784e5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月5号投稿.今天接收了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/05/39a731df1ff0b576e2c6bee247ac045d.jpg, createdBy=1a571649504, createdName=715498212, createdTime=Sat Sep 30 06:01:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]

2017-10-14 1311f10cd2m

20多天转投oncology report,老板不同意.撤稿了

340 0

[GetPortalCommentsPageByObjectIdResponse(id=549996, encodeId=3733549996fb, content=太耽误时间了.怎么这么无耻!scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, beContent=scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Dec 14 00:00:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549924, encodeId=714454992404, content=审稿速度:3.0 经验分享：9月份投稿，期间修图2次，中间transfer offered，之后邮件通知withdrawn,也是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8rWmC7IqnkYnlgBw4xSYXQNScbVfhIibs409oNsTMoZyLaxAPla2AWNS1IGSoxUC9FOYrH0MlDFQ/132, createdBy=379a2105901, createdName=scalpel_wielder, createdTime=Tue Dec 12 13:37:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549889, encodeId=07da549889bc, content=这个杂志submitted要多久?效率真够低的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Dec 11 10:17:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549838, encodeId=f9fd5498388f, content=submitted一周了.什么情况啊.效率真不敢恭维!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Dec 08 12:03:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549706, encodeId=aa8c549e068a, content=我也出现了这个问题，请问怎么拒绝转投？状态显示是transfer offeredIvyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, beContent=Ivyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170210/IMG589DE318D473F7832.jpg, createdBy=305b1731653, createdName=wxsession2fd6bdf4, createdTime=Mon Dec 04 17:12:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548223, encodeId=cdc35482237e, content=20多天转投oncology report,老板不同意.撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe5b2075564, createdName=1311f10cd2m, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548240, encodeId=2932548240c6, content=oncology report也有2.66...你老板咋想的?131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, beContent=131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4ac1648838, createdName=Ou Chunlin, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548116, encodeId=c5fb548116fa, content=7月底投稿，2周后受到邮件让改格式，改完迅速发过去，7+周过去了，刚刚受到邮件通知要under review了......那么这7+周他们在干什么呢....请问从under review到知道结果大概还要多久呀？一般几个reviewer呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12682133049, createdName=zhijiena_94096875, createdTime=Wed Oct 11 03:14:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547981, encodeId=da4b54e98109, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7月16日审稿，10月4日接受。期间小修一次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea411918519, createdName=BRIGHTINS, createdTime=Sat Oct 07 14:14:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547784, encodeId=094b54e784e5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月5号投稿.今天接收了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/05/39a731df1ff0b576e2c6bee247ac045d.jpg, createdBy=1a571649504, createdName=715498212, createdTime=Sat Sep 30 06:01:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]

2017-10-14 Ou Chunlin

oncology report也有2.66...你老板咋想的?131****5523 2017-10-14 00:00:00 发表:
20多天转投oncology report,老板不同意.撤稿了

131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了

216 0

[GetPortalCommentsPageByObjectIdResponse(id=549996, encodeId=3733549996fb, content=太耽误时间了.怎么这么无耻!scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, beContent=scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Dec 14 00:00:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549924, encodeId=714454992404, content=审稿速度:3.0 经验分享：9月份投稿，期间修图2次，中间transfer offered，之后邮件通知withdrawn,也是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8rWmC7IqnkYnlgBw4xSYXQNScbVfhIibs409oNsTMoZyLaxAPla2AWNS1IGSoxUC9FOYrH0MlDFQ/132, createdBy=379a2105901, createdName=scalpel_wielder, createdTime=Tue Dec 12 13:37:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549889, encodeId=07da549889bc, content=这个杂志submitted要多久?效率真够低的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Dec 11 10:17:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549838, encodeId=f9fd5498388f, content=submitted一周了.什么情况啊.效率真不敢恭维!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Dec 08 12:03:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549706, encodeId=aa8c549e068a, content=我也出现了这个问题，请问怎么拒绝转投？状态显示是transfer offeredIvyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, beContent=Ivyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170210/IMG589DE318D473F7832.jpg, createdBy=305b1731653, createdName=wxsession2fd6bdf4, createdTime=Mon Dec 04 17:12:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548223, encodeId=cdc35482237e, content=20多天转投oncology report,老板不同意.撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe5b2075564, createdName=1311f10cd2m, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548240, encodeId=2932548240c6, content=oncology report也有2.66...你老板咋想的?131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, beContent=131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4ac1648838, createdName=Ou Chunlin, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548116, encodeId=c5fb548116fa, content=7月底投稿，2周后受到邮件让改格式，改完迅速发过去，7+周过去了，刚刚受到邮件通知要under review了......那么这7+周他们在干什么呢....请问从under review到知道结果大概还要多久呀？一般几个reviewer呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12682133049, createdName=zhijiena_94096875, createdTime=Wed Oct 11 03:14:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547981, encodeId=da4b54e98109, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7月16日审稿，10月4日接受。期间小修一次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea411918519, createdName=BRIGHTINS, createdTime=Sat Oct 07 14:14:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547784, encodeId=094b54e784e5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月5号投稿.今天接收了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/05/39a731df1ff0b576e2c6bee247ac045d.jpg, createdBy=1a571649504, createdName=715498212, createdTime=Sat Sep 30 06:01:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]

2017-10-11 zhijiena_94096875

7月底投稿，2周后受到邮件让改格式，改完迅速发过去，7+周过去了，刚刚受到邮件通知要under review了......那么这7+周他们在干什么呢....请问从under review到知道结果大概还要多久呀？一般几个reviewer呀？

219 0

[GetPortalCommentsPageByObjectIdResponse(id=549996, encodeId=3733549996fb, content=太耽误时间了.怎么这么无耻!scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, beContent=scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Dec 14 00:00:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549924, encodeId=714454992404, content=审稿速度:3.0 经验分享：9月份投稿，期间修图2次，中间transfer offered，之后邮件通知withdrawn,也是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8rWmC7IqnkYnlgBw4xSYXQNScbVfhIibs409oNsTMoZyLaxAPla2AWNS1IGSoxUC9FOYrH0MlDFQ/132, createdBy=379a2105901, createdName=scalpel_wielder, createdTime=Tue Dec 12 13:37:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549889, encodeId=07da549889bc, content=这个杂志submitted要多久?效率真够低的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Dec 11 10:17:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549838, encodeId=f9fd5498388f, content=submitted一周了.什么情况啊.效率真不敢恭维!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Dec 08 12:03:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549706, encodeId=aa8c549e068a, content=我也出现了这个问题，请问怎么拒绝转投？状态显示是transfer offeredIvyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, beContent=Ivyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170210/IMG589DE318D473F7832.jpg, createdBy=305b1731653, createdName=wxsession2fd6bdf4, createdTime=Mon Dec 04 17:12:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548223, encodeId=cdc35482237e, content=20多天转投oncology report,老板不同意.撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe5b2075564, createdName=1311f10cd2m, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548240, encodeId=2932548240c6, content=oncology report也有2.66...你老板咋想的?131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, beContent=131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4ac1648838, createdName=Ou Chunlin, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548116, encodeId=c5fb548116fa, content=7月底投稿，2周后受到邮件让改格式，改完迅速发过去，7+周过去了，刚刚受到邮件通知要under review了......那么这7+周他们在干什么呢....请问从under review到知道结果大概还要多久呀？一般几个reviewer呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12682133049, createdName=zhijiena_94096875, createdTime=Wed Oct 11 03:14:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547981, encodeId=da4b54e98109, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7月16日审稿，10月4日接受。期间小修一次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea411918519, createdName=BRIGHTINS, createdTime=Sat Oct 07 14:14:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547784, encodeId=094b54e784e5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月5号投稿.今天接收了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/05/39a731df1ff0b576e2c6bee247ac045d.jpg, createdBy=1a571649504, createdName=715498212, createdTime=Sat Sep 30 06:01:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]

2017-10-07 BRIGHTINS

审稿速度:2.0 | 投稿命中率:75.0
经验分享：7月16日审稿，10月4日接受。期间小修一次。

206 0

[GetPortalCommentsPageByObjectIdResponse(id=549996, encodeId=3733549996fb, content=太耽误时间了.怎么这么无耻!scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, beContent=scalpel_wielder 2017-12-12 13:37:00 发表: 9月份投稿.期间修图2次.中间transfer offered. 之后邮件通知withdrawn,也是醉了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Dec 14 00:00:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549924, encodeId=714454992404, content=审稿速度:3.0 经验分享：9月份投稿，期间修图2次，中间transfer offered，之后邮件通知withdrawn,也是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8rWmC7IqnkYnlgBw4xSYXQNScbVfhIibs409oNsTMoZyLaxAPla2AWNS1IGSoxUC9FOYrH0MlDFQ/132, createdBy=379a2105901, createdName=scalpel_wielder, createdTime=Tue Dec 12 13:37:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549889, encodeId=07da549889bc, content=这个杂志submitted要多久?效率真够低的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Dec 11 10:17:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549838, encodeId=f9fd5498388f, content=submitted一周了.什么情况啊.效率真不敢恭维!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Dec 08 12:03:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549706, encodeId=aa8c549e068a, content=我也出现了这个问题，请问怎么拒绝转投？状态显示是transfer offeredIvyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, beContent=Ivyphx 2016-10-22 发表:: 研究方向：肿瘤;癌症; 我也被建议转投到Molecular and Clinical Oncology了，悲催，还不是sci, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170210/IMG589DE318D473F7832.jpg, createdBy=305b1731653, createdName=wxsession2fd6bdf4, createdTime=Mon Dec 04 17:12:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548223, encodeId=cdc35482237e, content=20多天转投oncology report,老板不同意.撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe5b2075564, createdName=1311f10cd2m, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548240, encodeId=2932548240c6, content=oncology report也有2.66...你老板咋想的?131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, beContent=131****5523 2017-10-14 00:00:00 发表: 20多天转投oncology report,老板不同意.撤稿了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4ac1648838, createdName=Ou Chunlin, createdTime=Sat Oct 14 00:00:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548116, encodeId=c5fb548116fa, content=7月底投稿，2周后受到邮件让改格式，改完迅速发过去，7+周过去了，刚刚受到邮件通知要under review了......那么这7+周他们在干什么呢....请问从under review到知道结果大概还要多久呀？一般几个reviewer呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12682133049, createdName=zhijiena_94096875, createdTime=Wed Oct 11 03:14:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547981, encodeId=da4b54e98109, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7月16日审稿，10月4日接受。期间小修一次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea411918519, createdName=BRIGHTINS, createdTime=Sat Oct 07 14:14:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547784, encodeId=094b54e784e5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月5号投稿.今天接收了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/05/39a731df1ff0b576e2c6bee247ac045d.jpg, createdBy=1a571649504, createdName=715498212, createdTime=Sat Sep 30 06:01:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]

2017-09-30 715498212

审稿速度:1.0 | 投稿命中率:50.0
经验分享：7月5号投稿.今天接收了.

188 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务